News

A new study led by Kasia Lipska examined whether newer diabetes medications might help people with type 2 diabetes reduce reliance on insulin. Using VA electronic health record data, researchers compared outcomes among patients starting a GLP-1 receptor agonist versus other commonly prescribed drug classes.

A new study in Neuropsychopharmacology provides a comprehensive genetic answer to the question: Why do certain people who try cannabis never develop a problem with addiction, while roughly one in 10 progresses to cannabis use disorder? Renato Polimanti, PhD, MSc, is the senior author.

Yale investigators, in collaboration with a team of international scientists, have nearly doubled the known genetic landscape of endometriosis, a chronic and often debilitating inflammatory disease affecting approximately 10% of women worldwide. Renato Polimanti, PhD, MSc, is senior author of the paper, published in Nature Genetics.

Investigators in the Yale Department of Psychiatry demonstrated that females and males report differently information regarding family history of Alzheimer’s disease. In particular, the scientists observed that socioeconomic factors and cognitive abilities contribute to altering the assessment of family history of Alzheimer’s disease in large-scale studies.

Brenda Cabrera-Mendoza, MD, PhD, postdoctoral associate in the Yale Department of Psychiatry, has been awarded a grant from MQ Mental Health Research for the study, “Stratification of Suicide Risk Through the Integration of Genetic and Clinical Factors.”

Yale Department of Psychiatry residents Eleni Friligkou, MD, MSc, and Joseph Luchsinger, MD, PhD, have been named co-first place recipients of the 2025 Lustman Award for Psychiatric Research.

Yale investigators, in collaboration with other institutions, conducted a new study published in JAMA Psychiatry to investigate how traumatic experiences and adverse events are differentially associated with endometriosis.

The Yale Center for the Science of Cannabis and Cannabinoids (YC-SCAN²) has announced grants over $600,000 to 14 Yale School of Medicine researchers for innovative projects to understand the impact of cannabis and cannabinoids on neurodevelopment and mental health.

Investigators in the Yale Department of Psychiatry investigated the genetic profiles of more than 1 million participants enrolled in multiple cohorts around the world. Leveraging this large dataset, they uncovered more than 100 genes associated with anxiety. Eleni Friligkou, MD, MSc, and Renato Polimanti, PhD, MSc, are first and senior authors, respectively.